Liver Transplant Denied by Insurance? MELD Score, Alcohol Policy, and How to Appeal

Liver transplantation is the definitive treatment for end-stage liver disease (ESLD) and acute liver failure. When insurance denies coverage for liver transplant evaluation or the procedure itself, patients with rapidly progressing liver disease have little time to navigate the appeals process. Understanding the key denial triggers — and how to counter them — can be the difference between life and death.

The MELD Score and Insurance Coverage

The Model for End-Stage Liver Disease (MELD) score is a validated mathematical formula that predicts 90-day mortality in patients with chronic liver disease. It incorporates serum bilirubin, creatinine, and international normalized ratio (INR). The MELD-Na variant adds serum sodium to improve predictive accuracy. UNOS uses the MELD score as the primary allocation criterion for deceased donor liver transplants.

For insurance purposes, the MELD score is one of the primary clinical metrics used to establish medical necessity. However:

• Many insurers have established their own MELD score thresholds for coverage that may not align with UNOS allocation criteria.
• A patient with a lower MELD score who is experiencing specific complications of portal hypertension (hepatic encephalopathy, refractory ascites, spontaneous bacterial peritonitis) may still require transplant evaluation even if MELD-based mortality prediction is below a threshold cutoff.
• Exception points (awarded by UNOS regional review boards for conditions not captured by the MELD formula, such as hepatocellular carcinoma) should be documented and included in the insurance appeal.

Alcohol-Related Liver Disease: Documentation Requirements

Alcoholic hepatitis and alcohol-related cirrhosis represent the fastest-growing indication for liver transplantation in the U.S. However, many insurers impose sobriety requirements for coverage of liver transplants related to alcohol-related liver disease (ARLD). Common insurer policies include:

• Six-month sobriety requirement prior to listing
• Documentation of alcohol use disorder (AUD) treatment
• Ongoing engagement with substance use treatment or AA/support programs
• Psychological evaluation addressing relapse risk

The six-month sobriety rule has been increasingly challenged in medical literature and by transplant centers. Studies show that carefully selected patients with severe alcoholic hepatitis who receive early liver transplantation have outcomes comparable to those who undergo transplantation after six months of sobriety. The American Association for the Study of Liver Diseases (AASLD) and the American Society of Transplantation (AST) have published guidance supporting individualized patient selection rather than rigid sobriety cutoffs.

If your denial cites sobriety requirements, appeal using:

• Current clinical guidelines questioning rigid sobriety cutoffs
• Documentation of robust psychosocial support and engagement with AUD treatment
• Your transplant team's multi-disciplinary psychosocial evaluation
• Evidence of insight into alcohol use disorder and relapse prevention planning

Living Donor Liver Transplantation

If deceased donor transplant coverage is being denied or delayed, living donor liver transplantation (LDLT) is an option that deserves parallel evaluation. LDLT involves a living donor donating a portion of their liver (right or left lobe), which regenerates in both recipient and donor.

Most insurers cover LDLT for the recipient if the transplant itself is covered. The donor evaluation and donor surgery costs are typically covered by the recipient's insurance under federal law and UNOS policy. If your insurer is denying or delaying coverage, ask whether they will authorize a living donor evaluation concurrently.

The UNOS Waitlist and Insurance Coverage Timing

Insurance coverage must be confirmed before a patient can be listed with UNOS. Delays in insurance authorization directly translate to delays in waitlist listing, which affect both organ allocation priority and outcomes.

If your insurer is not responding promptly to a Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization request for liver transplant evaluation or listing, document all communications and escalate to your state insurance department. Most states require insurers to respond to prior authorization requests for urgent or life-threatening conditions within 72 hours.

Hepatocellular Carcinoma (HCC) and the Milan Criteria

For patients with hepatocellular carcinoma superimposed on cirrhosis, UNOS applies the Milan criteria to determine transplant eligibility: a single lesion up to 5 cm, or up to three lesions each under 3 cm, with no vascular invasion or extrahepatic spread.

Insurers may cite Milan criteria when evaluating coverage. If your HCC is outside Milan criteria, document whether your center applies the UCSF or other expanded criteria, and whether downstaging treatment (chemoembolization, ablation) has been or is being attempted.

Building Your Appeal

Step 1: Document the MELD/MELD-Na score and trajectory. A rising MELD score over time demonstrates disease progression.

Step 2: Compile all records of liver disease complications — hospitalizations for encephalopathy, paracentesis procedures, variceal bleeding.

Step 3: If alcohol-related, document AUD treatment engagement and psychosocial evaluation in full.

Step 4: Have your hepatologist and transplant team write letters addressing each denial criterion specifically.

Step 5: Cite AASLD practice guidelines and UNOS allocation policy.

Step 6: Request expedited review given medical urgency. File simultaneously with your state insurance commissioner.

Fight Back With ClaimBack

Liver transplant denials demand an urgent, expert response. ClaimBack helps you build the clinical and legal argument to reverse your denial as quickly as possible.

Start your appeal with ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeal: Which to File